Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?

Mattia C. F. Prosperi, Sarah L. Ingham, Anthony Howell, Fiona Lalloo, Iain E. Buchan, Dafydd Gareth Evans. Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?. BMC Med. Inf. & Decision Making, 14:87, 2014. [doi]

Authors

Mattia C. F. Prosperi

This author has not been identified. Look up 'Mattia C. F. Prosperi' in Google

Sarah L. Ingham

This author has not been identified. Look up 'Sarah L. Ingham' in Google

Anthony Howell

This author has not been identified. Look up 'Anthony Howell' in Google

Fiona Lalloo

This author has not been identified. Look up 'Fiona Lalloo' in Google

Iain E. Buchan

This author has not been identified. Look up 'Iain E. Buchan' in Google

Dafydd Gareth Evans

This author has not been identified. Look up 'Dafydd Gareth Evans' in Google